Internal medicine

Tumor microenvironment

Immunotherapy

Immunogenic cell death

Cancer

Prodrug

Cytotoxicity

Cytotoxic T cell

Chemistry

In vitro

Immunology

Chemotherapy

Doxorubicin

Chemoimmunotherapy

Cancer research

Biochemistry

Medicine

Immune system

Cancer cell

Pharmacology

Biomaterials

The effective chemotherapeutic drug, doxorubicin (DOX), elicits immunogenic cell death (ICD) and additional anticancer immune responses during chemoth…

Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity